When will Beam Therapeutics submit a BLA for Risto-cel?
2.0 Pkt. (24h)Health & MedicineOne-OffWissenschaft1Mon
KalshiVerfügbarkeit prüfenKYC erforderlich2% GebührVerifizierte AuflösungsdatenOrdentlich kalibriertAktuelle implizite Wahrscheinlichkeit
before April 2027 93%Führend unter 6 Optionen
Marktqualitat
59 / 100
Mittlere Qualität24h-Volumen
431,8 €
Liquidität
17.363,3 €
Mittlere LiquiditätSpread
3.0 pt
Mittlerer SpreadMarktdaten
Aktualisiert vor 10 Minuten
24. März 26, 14:00 UTC1. Nov. 26, 05:00 UTC
Trends
Verwandte Märkte
Verwandte Fragen als Kontext, kein Vergleich gleichwertiger Kontrakte.
FDA decision: Ivonescimab by Summit Therapeutics (in 2026)
KalshiFDA decision: Saroglitazar by Zydus Therapeutics (in 2026)
KalshiWhen will Compass Pathways submit a NDA for COMP360 psilocybin?
KalshiWill we get room temperature superconductors before 2033?
Manifold MarketsWill we get room temperature superconductors before 2031?
Manifold MarketsWill we get room temperature superconductors before 2032?
Manifold MarketsRegeln
If Beam Therapeutics Inc. submits a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA before Sep 1, 2026, then the market resolves to Yes.
- If Beam Therapeutics Inc. submits a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA before Oct 1, 2026, then the market resolves to Yes.
- If Beam Therapeutics Inc. submits a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA before Nov 1, 2026, then the market resolves to Yes.
- If Beam Therapeutics Inc. submits a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA before Dec 1, 2026, then the market resolves to Yes.
- If Beam Therapeutics Inc. submits a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA before Jan 1, 2027, then the market resolves to Yes.
- If Beam Therapeutics Inc. submits a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA before Apr 1, 2027, then the market resolves to Yes.
Offene Märkte
Health & Medicine
POLYMARKETHantavirus pandemic in 2026?
- No+0.4pt97%
- Yes-0.4pt3%
- Gesamtvolumen
- 15,7 Mio. €
- 24h-Volumen
- 52.229,8 €
KALSHIMeasles cases in 2026?
- Above 4000+2.0pt99%
- Above 300099%
- Above 600061%
+2 weitere Ergebnisse
- Gesamtvolumen
- 870.445,2 €
- 24h-Volumen
- 2087,6 €
POLYMARKETNew pandemic in 2026?
- No-1.0pt93.1%
- Yes+1.0pt6.9%
- Gesamtvolumen
- 922.473,3 €
- 24h-Volumen
- 1758,2 €
KALSHICyclosporiasis cases reported in the US in 2026?
- Above 18k99%
- Above 6k99%
- Above 10k99%
+12 weitere Ergebnisse
- Gesamtvolumen
- 32.412,1 €
- 24h-Volumen
- 1299,1 €
KALSHIWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
- No97%
- Yes+0.4pt3%
- Gesamtvolumen
- 1,6 Mio. €
- 24h-Volumen
- 933,9 €
KALSHIHealthcare AI adoption in September
- Above 43%87%
- Above 43.75%59%
- Above 45%14%
+4 weitere Ergebnisse
- Gesamtvolumen
- 810,1 €
- 24h-Volumen
- 767 €
- FDA decision: Ivonescimab by Summit Therapeutics (in 2026)
- Measles cases in U.S. in 2026?
- Measles cases in U.S. by September 30?
- What will the average number of measles cases be during Trump's term?
- Will the FDA approve any psychedelic substance for medical use this year?
- Pandemic in 2026?
- How many human screwworm cases will be reported in the United States in 2026?
- When will Heidi Overton be confirmed as Commissioner of the FDA?
- Which countries will have an Ebola case in 2026?
- Ebola: new country confirmed before October 1?
- Will the FDA approve MDMA for PTSD?
Häufige Fragen
- Wie stehen die aktuellen Quoten für When will Beam Therapeutics submit a BLA for Risto-cel??
- Kalshi bewertet before April 2027 mit 93% (Stand: 11. September 2026).
- Wann wird When will Beam Therapeutics submit a BLA for Risto-cel? entschieden?
- When will Beam Therapeutics submit a BLA for Risto-cel? soll am 1. November 2026 entschieden werden.
- Wie wird When will Beam Therapeutics submit a BLA for Risto-cel? abgerechnet?
- Kalshi rechnet diesen Markt wie folgt ab: If Beam Therapeutics Inc. submits a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA before Sep 1, 2026, then the market resolves to Yes.